$58.9 MILLION SETTLEMENT
The Sheller whistleblower team announced a $58.9 milllion settlement with Shire Pharmaceuticals over off-label marketing of ADHD drugs Adderall and Vyvanse in September, 2014. Court documents detailing the civil allegations and settlement were signed by Shire and unsealed by the Office of the United States Attorney for the Eastern District of Pennsylvania. A Shire executive, […]
Sheller Whistleblower Settlement: Florida Pain Practice Pays $750,000
2014-02-25 Sheller, P.C. announced today that Sarasota Pain Associates, P.A. (SPA) and its owner, Dr. Steven Chun, have agreed to pay $750,000 to resolve allegations by the law firm’s whistleblower clients that SPA violated the False Claims Act by submitting false claims to Medicare for procedures and services that he did not perform. During the time […]
Sheller in Bloomberg Business on Whistleblowers and J&J $2.2B Settlement
Bloomberg Business Week 2013-12-09 Judy Doetterl was a sales representative for Johnson & Johnson (JNJ) in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at a national company sales meeting. U.S. prosecutors wanted to prove claims by Doetterl and others that J&J boosted sales by urging doctors to prescribe […]
Sheller in Philadelphia Inquirer on $2.2B Risperdal Settlement
Philadelphia Inquirer 2013-11-05 Sheller, P.C.’s representation of whistleblowers totals over $6 billion, with three of the top five pharmaceutical settlements in history: 2009: Pfizer $2.3 billion (Geodon) 2009: Eli Lilly & Co. $1.4 billion (Zyprexa) 2013: Johnson & Johnson $2.2 billion (Risperdal, Invega) and in 2010 : Astra Zeneca $520 million (Seroquel) WASHINGTON – Health-care […]
$2.2 Billion Settlement
With the $2.2B Risperdal settlement, Sheller, P.C.’s representation of whistleblowers totals over $6.4 billion, with three of the top five pharmaceutical settlements in history 2009: Pfizer $2.3 billion (Geodon) 2009: Eli Lilly & Co. $1.4 billion (Zyprexa) 2013: Johnson & Johnson $2.2 billion (Risperdal, Invega) 2010 : Astra Zeneca $520 million (Seroquel) WASHINGTON, November 4, […]
OIG Medicare/Medicaid Whistleblower Fraud Alert and WSJ on physician medical device distributorship
The Wall Street Journal 2013-07-26 The Wall Street Journal today published a front page story on the Department of Justice investigation into fraud in physician-owned distributorships of medical devices. Some instances of this type of Medicare/Medicaid fraud is reported by whistleblowers with representation of whistleblower law firms including Sheller, P.C. Healthcare and other professionals who […]
$1.4 Billion Whistleblower Settlement
2009-01-15 Sheller, P.C.’s whistleblower/qui tam clients help U.S. government recover $1.4 billion record settlement and criminal fine in Eli Lilly & Company Zyprexa marketing case. [pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/ShellerPC_ZyprexaNewsRelease_200901152.pdf”]
